1. Howard, AD, Feighner, SD, Cully, DF, et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science. 1996;273(5277):974–9717.
Google Scholar | Crossref | Medline2. Bowers, CY, Momany, FA, Reynolds, GA, Hong, A. On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology. 1984;114(5):1537–1545.
Google Scholar | Crossref | Medline3. Bowers, CY . GH releasing peptides – structure and kinetics. J Pediatr Endocrinol Metab. 1993;6(1):21–31.
Google Scholar | Crossref4. Deghenghi, R, Cananzi, MM, Torsello, A, Battisti, C, Muller, EE, Locatelli, V. GH-releasing activity of hexarelin, a new growth hormone releasing peptide, in infant and adult rats. Life Sci. 1994;54(18):1321–1328.
Google Scholar | Crossref | Medline5. Patchett, AA, Nargund, RP, Tata, JR, et al. Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue. Proc Natl Acad Sci U S A. 1995;92(15):7001–7005.
Google Scholar | Crossref | Medline6. Elias, KA, Ingle, GS, Burnier, JP, et al. In vitro characterization of four novel classes of growth hormone-releasing peptide. Endocrinology. 1995;136(12):5694–5699.
Google Scholar | Crossref | Medline7. Raun, K, Hansen, BS, Johansen, NL, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552–561.
Google Scholar | Crossref | Medline8. Moulin, A, Ryan, J, Martinez, J, Fehrentz, JA. Recent developments in ghrelin receptor ligands. ChemMedChem. 2007;2(9):1242–1259.
Google Scholar | Crossref | Medline9. Ueberberg, B, Unger, N, Saeger, W, Mann, K, Petersenn, S. Expression of ghrelin and its receptor in human tissues. Horm Metab Res. 2009;41(1):814–821.
Google Scholar | Crossref | Medline10. Gnanapavan, S, Kola, B, Bustin, S, et al. The tissue distribution of mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab. 2002;87(6):2988–2991.
Google Scholar | Crossref | Medline11. Kojima, M, Hosoda, H, Date, Y, Nakazato, M, Matsuo, H, Kangawa, K. Ghrelin is a growth-hormone- releasing acylated peptide from stomach. Nature. 1999;402(6762):656–660.
Google Scholar | Crossref | Medline | ISI12. Zhu, X, Cao, Y, Voodg, K, Steiner, DF. On the processing of proghrelin to ghrelin. J Biol Chem. 2006;281(50):38867–38870.
Google Scholar | Crossref | Medline13. Yang, J, Brown, MS, Liang, G, Grishin, NV, Goldstein, JL. Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell. 2008;132(3):387–396.
Google Scholar | Crossref | Medline14. Gutierrez, JA, Solenberg, PJ, Perkins, DR, et al. Ghrelin octanoylation mediated by an orphan lipid transferase. Proc Natl Acad Sci U S A. 2008;105(17):6320–6325.
Google Scholar | Crossref | Medline15. Lim, CT, Kola, B, Grossman, A, Korbonits, M. The expression of ghrelin O-acyltransferase (GOAT) in human tissues. Endocr J. 2011;58(8):707–710.
Google Scholar | Crossref | Medline16. Bednarek, MA, Feighner, SD, Pong, SS, et al. Structure – Function studies on the new growth hormone-releasing peptide, ghrelin: Minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a. J Med Chem. 2000;43(23):4370–4376.
Google Scholar | Crossref | Medline17. Chen, CY, Inui, A, Asakawa, A, et al. Des-acyl ghrelin acts by CRF type 2 receptors to disrupt fasted stomach motility in conscious rats. Gastroenterology. 2005;129(1):8–25.
Google Scholar | Crossref | Medline18. Zanetti, M, Cappellari, GG, Graziani, A, Barazzoni, R. Unacylated ghrelin improves vascular dysfunction and attenuates atherosclerosis during high-fat diet consumption in rodents. Int J Mol Sci. 2019;20(3):499.
Google Scholar | Crossref19. Huynh, DN, Elimam, H, Bessi, VL, et al. A linear fragment of unacylated ghrelin (UAG 6−13) protects against myocardial ischemia/reperfusion injury in mice in a growth hormone secretagogue receptor-independent manner. Front Endocrinol (Lausanne). 2019;9:798.
Google Scholar | Crossref | Medline20. Allas, S, Caixàs, A, Poitou, C, et al. AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial. PLoS One. 2018;13(1):e0190849.
Google Scholar | Crossref | Medline21. Yin, Y, Li, Y, Zhang, W. The growth hormone secretagogue receptor: its intracellular signaling and regulation. Int J Mol Sci. 2014;15(3):4837–4855.
Google Scholar | Crossref | Medline22. Chow, KBS, Sun, J, Man Chu, K, Tai Cheung, W, Cheng, CHK, Wise, H. The truncated ghrelin receptor polypeptide (GHS-R1b) is localized in the endoplasmic reticulum where it forms heterodimers with ghrelin receptors (GHS-R1a) to attenuate their cell surface expression. Mol Cell Endocrinol. 2012;348(1):247–254.
Google Scholar | Crossref | Medline23. Mear, Y, Enjalbert, A, Thirion, S. GHS-R1a constitutive activity and its physiological relevance. Front Neurosci. 2013;7:87.
Google Scholar | Crossref | Medline24. Holst, B, Cygankiewicz, A, Jensen, TH, Ankersen, M, Schwartz, TW. High constitutive signaling of the ghrelin receptor – identification of a potent inverse agonist. Mol Endocrinol. 2003;17(11):2201–2210.
Google Scholar | Crossref | Medline25. Ge, X, Yang, H, Bednarek, MA, et al. LEAP2 is an endogenous antagonist of the ghrelin receptor. Cell Metab. 2018;27(2):461–469.e6.
Google Scholar | Crossref | Medline26. Krause, A, Sillard, R, Kleemeier, B, et al. Isolation and biochemical characterization of LEAP-2, a novel blood peptide expressed in the liver. Protein Sci. 2003;12(1):143–152.
Google Scholar | Crossref | Medline27. Wang, JH, Li, HZ, Shao, XX, et al. Identifying the binding mechanism of LEAP2 to receptor GHSR1a. FEBS J. 2019;286(7):1332–1345.
Google Scholar | Crossref | Medline28. M’Kadmi, C, Cabral, A, Barrile, F, et al. N-Terminal Liver-Expressed Antimicrobial Peptide 2 (LEAP2) region exhibits inverse agonist activity toward the ghrelin receptor. J Med Chem. 2019;62(2):965–973.
Google Scholar | Crossref | Medline29. Lv, Y, Liang, T, Wang, G, Li, Z. Ghrelin, a gastrointestinal hormone, regulates energy balance and lipid metabolism. Biosci Rep. 2018;38(5):BSR20181061.
Google Scholar | Crossref | Medline30. Mihalache, L, Gherasim, A, Niţ, O, et al. Effects of ghrelin in energy balance and body weight homeostasis. Hormones. 2016;15(2):186–196.
Google Scholar | Crossref | Medline31. Kurowska, P, Mlyczynska, E, Rak, A. Effect of ghrelin on the apoptosis of various cells. A critical review. J Physiol Pharmacol. 2019;70(1):3–13.
Google Scholar32. Mao, Y, Tokudome, T, Kishimoto, I. Ghrelin and blood pressure regulation. Curr Hypertens Rep. 2016;18(2):15.
Google Scholar | Crossref | Medline33. Tokudome, T, Otani, K, Miyazato, M, Kangawa, K. Ghrelin and the heart. Peptides. 2019;111:42–46.
Google Scholar | Crossref | Medline34. Chen, W, Enriori, PJ. Ghrelin: a journey from GH secretagogue to regulator of metabolism. Transl Gastrointest Cancer. 2015;4(1):14–27.
Google Scholar35. Colldén, G, Tschöp, MH, Müller, TD. Therapeutic potential of targeting the ghrelin pathway. Int J Mol Sci. 2017;18(4):798.
Google Scholar | Crossref36. da Silva Pereira, JA, da Silva, FC, de Moraes-Vieira, PMM. The impact of ghrelin in metabolic diseases: an immune perspective. J Diabetes Res. 2017;2017:4527980.
Google Scholar | Medline37. Soares, JB, Roncon-Albuquerque, R, Leite-Moreira, A. Ghrelin and ghrelin receptor inhibitors: agents in the treatment of obesity. Expert Opin Ther Targets. 2008;12(9):1177–1189.
Google Scholar | Crossref | Medline38. Costantino, L, Barlocco, D. Ghrelin receptor modulators: a patent review (2011-2014). Expert Opin Ther Pat. 2014;24(9):1007–1019.
Google Scholar | Crossref | Medline39. Cameron, KO, Bhattacharya, SK, Loomis, AK. Small molecule ghrelin receptor inverse agonists and antagonists. J Med Chem. 2014;57(21):8671–8691.
Google Scholar | Crossref | Medline40. Vodnik, M, Štrukelj, B, Lunder, M. Ghrelin receptor ligands reaching clinical trials: from peptides to peptidomimetics; from agonists to antagonists. Horm Metab Res. 2016;48(1):1–15.
Google Scholar | Medline41. Beiras-Fernandez, A, Kreth, S, Weis, F, et al. Altered myocardial expression of ghrelin and its receptor (GHSR-1a) in patients with severe heart failure. Peptides. 2010;31(12):2222–2228.
Google Scholar | Crossref | Medline42. Lin, TC, Hsiao, M. Ghrelin and cancer progression. Biochim Biophys Acta. 2017;1868(1):51–57.
Google Scholar | Crossref43. Wang, W, Chen, ZX, Guo, DY, Tao, YX. Regulation of prostate cancer by hormone-responsive G protein-coupled receptors. Pharmacol Ther. 2018;191:135–147.
Google Scholar | Crossref | Medline44. Grönberg, M, Nilsson, C, Markholm, I, et al. Ghrelin expression is associated with a favorable outcome in male breast cancer. Sci Rep. 2018;8(1):13586.
Google Scholar | Crossref | Medline45. Chopin, LK, Seim, I, Walpole, CM, Herington, AC. The Ghrelin axis-does it have an appetite for cancer progression? Endocr Rev. 2012;33(6):849–891.
Google Scholar | Crossref | Medline46. Nikolopoulos, D, Theocharis, S, Kouraklis, G. Ghrelin’s role on gastrointestinal tract cancer. Surg Oncol. 2010;19(1):e2–e10.
Google Scholar | Crossref | Medline47. Lu, C, McFarland, MS, Nesbitt, RL, et al. Ghrelin receptor as a novel imaging target for prostatic neoplasms. Prostate. 2012;72(8):825–833.
Google Scholar | Crossref | Medline48. Aleksova, A, Beltrami, AP, Bevilacqua, E, et al. Ghrelin derangements in idiopathic dilated cardiomyopathy: impact of myocardial disease duration and left ventricular ejection fraction. J Clin Med. 2019;8(8):1152.
Google Scholar | Crossref49. Machado, JF, Silva, RD, Melo, R, Correia, JDG. Less exploited GPCRs in precision medicine: targets for molecular imaging and theranostics. Molecules. 2018;24(1):49.
Google Scholar | Crossref50. Iliopoulos-Tsoutsouvas, C, Kulkarni, RN, Makriyannis, A, Nikas, SP. Fluorescent probes for G-protein-coupled receptor drug discovery. Expert Opin Drug Discov. 2018;13(10):933–947.
Google Scholar | Crossref | Medline51. Matsumoto, M, Hosoda, H, Kitajima, Y, et al. Structure-activity relationship of ghrelin: pharmacological study of ghrelin peptides. Biochem Biophys Res Commun. 2001;287(1):142–146.
Google Scholar | Crossref | Medline52. Van Craenenbroeck, M, Gregoire, F, De Neef, P, Robberecht, P, Perret, J. Ala-scan of ghrelin (1-14): interaction with the recombinant human ghrelin receptor. Peptides. 2004;25(6):959–965.
Google Scholar |